SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-20-011266
Filing Date
2020-05-11
Accepted
2020-05-11 15:02:42
Documents
55
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 550659
2 EXHIBIT 10.2 ex10_2.htm EX-10.2 54941
3 EXHIBIT 10.3 ex10_3.htm EX-10.3 27425
4 EXHIBIT 10.4 ex10_4.htm EX-10.4 32580
5 EXHIBIT 10.5 ex10_5.htm EX-10.5 75469
6 EXHIBIT 10.6 ex10_6.htm EX-10.6 44767
7 EXHIBIT 31.1 ex31_1.htm EX-31.1 11381
8 EXHIBIT 31.2 ex31_2.htm EX-31.2 11179
9 EXHIBIT 32.1 ex32_1.htm EX-32.1 5652
  Complete submission text file 0001140361-20-011266.txt   4317639

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT bstc-20200331.xml EX-101.INS 733951
11 XBRL TAXONOMY EXTENSION SCHEMA bstc-20200331.xsd EX-101.SCH 32626
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bstc-20200331_cal.xml EX-101.CAL 43412
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bstc-20200331_def.xml EX-101.DEF 219266
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE bstc-20200331_lab.xml EX-101.LAB 556099
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bstc-20200331_pre.xml EX-101.PRE 336422
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19879 | Film No.: 20864330
SIC: 2834 Pharmaceutical Preparations